2m 2m 2m 2m 2m 2m 2m
IBIO (IBIO)
NASDAQ
$1.10-$0.01 (-0.90%)
Price as of Oct 02, 2026 7:06 PM EDT- $71.4MMarket Cap
- 33.11%1-Year Change
- BiotechnologyIndustry
IBIO (IBIO)
$1.10-$0.01 (-0.90%)
IBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.11 | ||
Change | -$0.07 (-5.93%) | ||
Open | $1.18 | ||
High | $1.21 | ||
Low | $1.10 | ||
Previous Close | $1.18 | ||
Volume | 341,275 | ||
30-Day Average Volume | 584,297 | ||
1-Week Change | -7.50% | ||
1-Month Change | -11.90% | ||
1-Year Change | 33.11% | ||
3-Year Change | -81.71% | ||
5-Year Change | -99.79% | ||
Fundamentals | |||
Shares Outstanding | 64.3M | ||
Total Assets | $99.1M | ||
Market Cap | $71.4M | ||
Enterprise Value | $15.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$10.6M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$10.6M | ||
EBITDA | -$10.6M | ||
Net Working Capital | $80.5M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | 1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/29/2023 | ||
Earnings & Revenue